Bullish Two Hundred Day Moving Average Cross - BCRX

In trading on Monday, shares of BioCryst Pharmaceuticals, Inc. ( BCRX) crossed above their 200 day moving average of $10.97, changing hands as high as $11.17 per share. BioCryst Pharmaceuticals, Inc. shares are currently trading up about 2.2% on the day. The chart below shows the one year performance of BCRX shares, versus its 200 day moving average:

Click here to find out which 9 other stocks recently crossed above their 200 day moving average »

BioCryst Pharmaceuticals, Inc. 200 Day Moving Average Chart

Looking at the chart above, BCRX's low point in its 52 week range is $7.85 per share, with $14.62 as the 52 week high point — that compares with a last trade of $10.98.

According to the ETF Finder at ETF Channel, BCRX makes up 1.12% of the SPDR S&P Biotech ETF ( XBI) which is trading higher by about 2% on the day Monday.

If you liked this article you might like

FDA OKs BioCryst's Rapivab for Pediatric Indication - Biotech Movers

Biotech Movers: BioCryst, Omeros, Radius Health

Biotech Movers: Loxo, NewLink, BioCryst

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

Biotech Premarket Movers: Esperion, Minerva and BioCryst